Healthcare of Ontario Pension Plan Trust Fund Has $718,000 Stock Position in Healthpeak Properties, Inc. $DOC

Posted by Brian Himes on Aug 3rd, 2026

Healthcare of Ontario Pension Plan Trust Fund reduced its holdings in Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 94.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,671 shares of the real estate investment trust’s stock after selling 745,065 shares during the period. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Healthpeak Properties were worth $718,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the business. WPG Advisers LLC lifted its position in shares of Healthpeak Properties by 270.2% in the fourth quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock worth $26,000 after purchasing an additional 1,197 shares in the last quarter. Advocate Investing Services LLC purchased a new position in Healthpeak Properties during the fourth quarter valued at approximately $26,000. Elyxium Wealth LLC purchased a new position in Healthpeak Properties during the fourth quarter valued at approximately $31,000. Clearstead Advisors LLC grew its position in Healthpeak Properties by 166.3% during the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock valued at $31,000 after purchasing an additional 1,216 shares in the last quarter. Finally, CYBER HORNET ETFs LLC acquired a new position in Healthpeak Properties in the 2nd quarter valued at approximately $33,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Trading Down 0.0%

Shares of NYSE:DOC opened at $21.83 on Monday. The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15. The stock has a market capitalization of $15.05 billion, a PE ratio of 68.21, a P/E/G ratio of 3.39 and a beta of 1.01. Healthpeak Properties, Inc. has a 1 year low of $15.70 and a 1 year high of $22.95. The firm has a fifty day moving average price of $21.01 and a 200 day moving average price of $18.66.

Healthpeak Properties (NYSE:DOC – Get Free Report) last posted its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The company had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. During the same period last year, the company earned $0.46 earnings per share. The business’s revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Analysts expect that Healthpeak Properties, Inc. will post 1.75 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be paid a $0.1017 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 5.6%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties’s dividend payout ratio (DPR) is presently 381.25%.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on DOC shares. Royal Bank Of Canada boosted their price target on shares of Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a report on Thursday, May 14th. Wall Street Zen raised Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Sunday, May 10th. BMO Capital Markets boosted their target price on Healthpeak Properties from $20.00 to $24.00 and gave the company an “outperform” rating in a research note on Monday, June 15th. UBS Group upped their target price on Healthpeak Properties from $19.00 to $21.50 and gave the stock a “neutral” rating in a research report on Wednesday, July 8th. Finally, Raymond James Financial initiated coverage on Healthpeak Properties in a research note on Wednesday, June 17th. They set a “market perform” rating for the company. Four analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $20.62.

View Our Latest Analysis on Healthpeak Properties

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the sale, the insider owned 7,636 shares of the company’s stock, valued at $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.23% of the company’s stock.

Healthpeak Properties Profile

(Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.